Kurma Partners
Paris, France
Quick Facts
- AUM
- $500M
- AUM Category
- $100M-$500M
- Typical Ticket Size
- $5M - $20M
- Headquarters
- Paris, France
- Founded
- 2011
- Team Size
- 11-50
About Kurma Partners
Kurma Partners is a Paris-based private equity firm that specializes in the life sciences and healthcare sectors, with a strong emphasis on innovation-driven companies. The firm adopts a thematic investment philosophy that seeks to identify and capitalize on trends in healthcare and biotechnology, particularly those that address unmet medical needs or promote advancements in healthcare technology. Kurma Partners typically focuses on growth capital investments, targeting companies that are in the later stages of development and poised for significant scaling. Their investment strategy is built on a thorough understanding of market dynamics and the scientific landscape, ensuring that they align their portfolio with sustainable growth trajectories. The firm’s sector expertise encompasses a variety of sub-sectors within life sciences, including pharmaceuticals, medical devices, and digital health. Kurma Partners actively seeks to invest in companies that are developing innovative therapeutics, diagnostics, and healthcare solutions that enhance patient care and improve clinical outcomes. By concentrating on these specific sectors, the firm has developed a deep knowledge base and a robust network of industry contacts, which are crucial for driving value creation in its portfolio companies. This focus enables Kurma Partners to leverage its scientific and operational expertise effectively, providing strategic guidance and operational support to its investees. What sets Kurma Partners apart in the competitive private equity landscape is its commitment to fostering innovation while maintaining a rigorous approach to risk management. The firm emphasizes collaboration with entrepreneurs and management teams, providing them not only with capital but also with strategic insights and operational support to help navigate the complexities of the life sciences sector. This partnership-oriented approach is indicative of their belief in the importance of aligning interests for long-term success. For interim executives considering a partnership with Kurma Partners, it is essential to recognize the firm’s emphasis on operational excellence and strategic growth. Working with Kurma may involve engaging with companies that are at critical inflection points, requiring interim executives to bring expertise in scaling operations, navigating regulatory landscapes, and driving strategic initiatives. The firm values executives who can integrate quickly into teams, provide decisive leadership, and contribute to the ongoing success of portfolio companies, making them a valuable partner in the private equity ecosystem.
Investment Focus
Sectors: Healthcare, Technology
Investment Stages: Venture, Growth
Portfolio Focus: HealthTech, DeepTech
Regional Offices
- Paris
Connect with Kurma Partners
Frequently Asked Questions
- Is Kurma Partners a private equity firm?
- Yes, Kurma Partners is a private equity firm headquartered in Paris, France, founded in 2011.
- What is Kurma Partners's AUM (assets under management)?
- Kurma Partners manages approximately $500M in assets under management.
- What is Kurma Partners's typical ticket size?
- Kurma Partners typically invests $5M - $20M per deal.
- Where is Kurma Partners headquartered?
- Kurma Partners is headquartered in Paris, France. Regional offices include Paris.
- What sectors does Kurma Partners invest in?
- Kurma Partners invests across Healthcare, Technology.
- What investment stages does Kurma Partners focus on?
- Kurma Partners focuses on Venture, Growth investments.
- When was Kurma Partners founded?
- Kurma Partners was founded in 2011.
Profile data is compiled from publicly available sources and AI analysis for the Interim community. Information is not endorsed by Kurma Partners; verify critical details directly with the firm.